GlassScriptPhysician profile
Joe Danko
NPI 1154797579
$1,664.85
in general payments reported to CMS, 2019-2025
16 companies · $493 in 2025
The $493 reported for 2025 was more than what 76% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $191 · 2022: $401 · 2023: $431 · 2024: $150 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $598.60 | 2022-2025 | |
| Horizon Therapeutics Plc | $269.97 | 2021-2022 | |
| Spinal Simplicity, LLC | $142.57 | 2025 | Ha Minuteman G3-R |
| Nevro Corp. | $122.06 | 2023-2024 | Senza |
| Nalu Medical, INC. | $94.59 | 2021-2024 | Nalu Neurostimulation System |
| Globus Medical, INC. | $76.96 | 2025 | Senza, Omnia |
| Si-Bone, INC. | $72.99 | 2025 | |
| Painteq LLC | $52.84 | 2023-2024 | Painteq |
| Averitas Pharma INC. | $47.34 | 2023 | Qutenza |
| Boston Scientific Corporation | $46.23 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.25 | 2022 | |
| Biotronik Nro, INC. | $28.63 | 2025 | Prospera |
| Scilex Pharmaceuticals INC. | $24.97 | 2024 | |
| Biodelivery Sciences International, INC. | $15.45 | 2021 | |
| Spineology INC. | $13.98 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $13.42 | 2024 | Prolate, Nalocet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Danko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.